Author(s):
Yazan Batineh, Qutaiba Ahmed Al Khames Aga, Kawthar Faris Nassir, Tharwat I Sulaiman, Ali Abbas Al-Gharawi, Jawad I Rasheed, Zaid Al Madfai, Mutaz A. Sheikh Salem, Luma Ahmed Al Khames Aga, Manhal Yasseen Rijab Agha, Eamon Abdullah
Email(s):
qutaiba975@gmail.com , qibrahim@philadelphia.ed.jo
DOI:
10.52711/0974-360X.2022.00863
Address:
Yazan Batineh1, Qutaiba Ahmed Al Khames Aga1*, Kawthar Faris Nassir2, Tharwat I Sulaiman2, Ali Abbas Al-Gharawi2, Jawad I Rasheed2, Zaid Al Madfai3, Mutaz A. Sheikh Salem1, Luma Ahmed Al Khames Aga4, Manhal Yasseen Rijab Agha5, Eamon Abdullah6
1Department of Clinical Sciences, Faculty of Pharmacy, Philadelphia University, Amman, Jordan.
2Bagdad Teaching Hospital, Medical City Baghdad, Iraq.
3College of Medicine, Baghdad University, Baghdad, Iraq.
4COVID-19 Testing Specialist Atechy Group Cardiff, Wales, UK.
5University Hospital of Wales, Department of Orthopedic Cardiff, UK.
6St. George’s University, Grenada, West Indies.
*Corresponding Author
Published In:
Volume - 15,
Issue - 11,
Year - 2022
Cite this article:
Yazan Batineh, Qutaiba Ahmed Al Khames Aga, Kawthar Faris Nassir, Tharwat I Sulaiman, Ali Abbas Al-Gharawi, Jawad I Rasheed, Zaid Al Madfai, Mutaz A. Sheikh Salem, Luma Ahmed Al Khames Aga, Manhal Yasseen Rijab Agha, Eamon Abdullah. Fenofibrate and Statins in Patients with COVID-19. Research Journal of Pharmacy and Technology. 2022; 15(11):5132-8. doi: 10.52711/0974-360X.2022.00863